- Open Access
Discussion of field effects after intraovarian injection of autologous platelet-rich plasma
Bulletin of the National Research Centre volume 47, Article number: 52 (2023)
In the pre-menopausal ovary, the oocyte does not develop in isolation. Stroma, perivascular cells, immune cells, granulosa cells and endothelium are unequivocally active, and compelling evidence are also available placing germline stem cells within this milieu. Indeed, the local cytoarchitecture network of collagen, proteoglycans, polysaccharides, and fibrous proteins jointly influence endocrine, nutrient, and osmotic fluid movement vital to eggs. After transiting basal lamina, these moieties can directly determine follicular growth and oocyte metabolism.
Main body of the abstract
Over time, this support apparatus changes to dampen crucial biochemical inputs and eventually disconnects the oocyte from its own regulatory grid. Background factors extrinsic to the oocyte such as stroma and extracellular matrix thus contribute to overall reproductive fitness. Both menopause and infertility are thus distinct clinical manifestations of a common knock-down of ovarian competence. While treatments for symptomatic menopause and infertility traditionally depend on standard hormone replacement therapy or synthetic gonadotropins, autologous platelet rich plasma (PRP) has arrived as an alternative method to improve ovarian reserve.
Intraovarian PRP is usually considered to interact mainly with follicles or oocyte precursors, although other ovarian components also respond to platelet cytokines. Cross-discipline PRP effects measured in similar (non-reproductive) stroma and tissue matrix systems are examined here, with a view to promote greater research bandwidth for intraovarian PRP.
How many distinct cell types are resident in the adult human ovary, and are connections across these sets relevant to oocyte recruitment and support? These queries received attention in a recent transcriptional analysis of ovarian cellular components which identified endothelial cells, granulosa cells, immune cells, oocytes, perivascular cells, and stroma (Wagner et al. 2020). As the study found no ovarian stem cells among the six cell populations present in the adult human ovary, it tended to endorse the traditional paradigm concerning age-limited ovarian reserve. However, the conspicuous absence of ovarian stem cells was later explained by suboptimal centrifugation parameters which would predictably fail to capture them (Bhartiya and Sharma 2020). Based on this critique, a different laboratory protocol should update or correct the ovary cell constituent roster to include germline stem cells.
The issue again drew notice when Tocci (Tocci 2022) articulated a detailed challenge to a position framed by Oktem (Oktem 2022) in a debate on sequential stimulated IVF cycles. During this exchange unrelated to ‘ovarian rejuvenation’, data aligning with Bhartiya and Sharma (2020) recalled that two distinct stem cell types localize to the adult human ovarian surface epithelium: Very small embryonic-like (VSEL) stem cells in latency, as well as mitotically active ovarian stem cells (Parte et al. 2013; White et al. 2012; Virant-Klun et al. 2013). And within this physiologic niche, somatic cells locally facilitate the transition of ovarian stem cells to competent oocytes (Tocci 2022; Bhartiya 2015; Sills and Wood 2019).
Information on ovarian substructure and function produced from various experts permits a new merger of research themes, guiding a better understanding of intraovarian PRP. For example, when embryology/IVF outcomes data after intraovarian PRP were first published (Sills et al. 2018), two mechanisms were hypothesized for the follicular action of platelet cytokines within the adult ovary. Unfortunately neglected in that proposal were any putative extra-follicular contributions evoked by PRP, discussed here to revise and extend prior work.
PRP: Juxta-follicular considerations
Descriptions of autologous platelet growth factors in women’s reproductive health tend to center on PRP (or its derivatives) placed into the uterus or ovarian tissue. For the latter, the focus is generally on follicular or oocyte responses but a therapeutic contribution by PRP to targets outside the oocyte should not be discounted. The observation that intraovarian injection of fresh, autologous activated PRP increased serum anti-mullerian hormone (AMH) in poor-responder fertility patients, and that this effect was correlated to baseline platelet concentration rather than age or infertility duration (Sills et al. 2018) implicates granulosa cells as a key operator in PRP response. While prior work has outlined how recruitment of de novo oocytes, presumably from latent ovarian stem cells may explain how intraovarian PRP works (Sills and Wood 2019), how this intervention might change the extra-follicular milieu remains to be characterized.
To appreciate the structure and function of the extracellular matrix, an inventory of relevant proteins is essential (Hynes and Naba 2012). That PRP or its cytokine derivatives may impact connective tissues or ovarian stroma is inferred from actions (Cenni et al. 2009; Wang et al. 2021; Scopelliti et al. 2022; Moulavi et al. 2020; Liu et al. 2022; Ahmed et al. 2006) in better studied non-ovarian settings (see Table 1).
When human platelet-derived cytokines as purified exosome products are cultured with various endometrial specimens, uptake of platelet factors yields marked cell proliferation and enhanced wound healing (Miller et al. 2022). This advances prior research (Sak et al. 2013) which found growth factors at midcycle to be lower in recurrent implantation failure vs. healthy controls. Autologous platelet cytokines placed into the endometrial compartment to rectify this shortage did increase embryo implantation (Nazari et al. 2016; Hajipour et al. 2021), suggesting a beneficial role at the blastocyst-endometrium connective tissue interface. Although crosstalk between ovarian follicles and the extracellular field is important, this is often eclipsed by direct receptor-ligand interactions involving membrane bound receptors at the follicle surface.
As discussed previously (Rickers and Sills 2022), a high leukocyte fraction in the platelet releasate generally favors production of proinflammatory cytokines likely impacting Type I collagen synthesis and alkaline phosphatase by osteoblasts (Baca-Gonzalez et al. 2022). Dermatology data compiled by Yunus et al. (2022) found PRP to be an effective therapeutic modality for skin rejuvenation, wound healing, and androgenic alopecia. Another cosmetic condition of unknown etiology is melasma, a superficial connective tissue pigmentation disorder where management with PRP has been closely studied (Tuknayat et al. 2021; Magistretti et al. 2022). Since PRP can produce such corrective or regenerative effects involving connective tissue outside the ovary, comparable activity within the ovary also seems plausible.
Of note, Luyckx and colleagues (2014) were the first to report survival & growth of isolated murine ovarian follicles after autologous ovarian cell transplant to a fibrin scaffold. Experimental evidence of platelet-derived factors as matrix-modulators also exists from bioengineered cartilage with cells able to migrate on PRP fibers to form cartilaginous tissue (Wu et al. 2022). Similar tissue engineering research (Zhao et al. 2022) has detailed PRP-integrated alginate gelatin composite hydrogel bioinks, where PLT cytokines appear to assist seeded cell behavior, form vascular endothelial cells, and organize macrophage polarization in a paracrine manner. When damaged cornea was treated with PRP, the basal epithelium, intermediate layer, and the superficial squamous layer all appeared histologically indistinguishable from healthy controls (Hashem 2020). If similar connective tissue effects were operant in ovarian analogs after PRP treatment, this would be distinct from oocyte programming and development to help explain early results (Sills et al. 2018). As ongoing work continues, use of PRP in other (e.g., in situ bioprinting) contexts has already shown it can contribute to angiogenesis, modulated inflammation, and faster wound closure (Zhao et al. 2022).
From serum AMH responses observed after intraovarian PRP (Sills et al. 2020), it is possible that post-treatment ovarian effects beyond the oocyte are also regulated by ambient PLT concentration. In addition to baseline PLT number, the activation particulars for PLTs offer opportunity for refinement. Cytokines and growth factors may be released via PLT activation using 100 mg/mL calcium gluconate (10%), 100 ng/mL convulxin, 50 µM TRAP-6, 5 nM thrombin, as well as other reagents (Rickers and Sills 2022; Heinzmann et al. 2021). One drawback of ‘ovarian rejuvenation’ may be its relatively brief biological activity for connective targets (Rao et al. 2022). However, this attribute may ultimately explain why a hyperstimulation response has never been reported with intraovarian PRP (Sills et al. 2022). Ongoing research may supply some answers once specific ovarian stromal responses following PRP are elucidated. For example, signaling changes induced in stroma after intraovarian PRP may enable or enforce moving germline stem cells into an oocyte lineage (Sills and Wood 2022).
Notwithstanding any putative restorative action on ovarian follicles/oocyte precursors, research in other areas has confirmed that platelet-derived cytokines do have effects on connective tissue (Rastegar Adib et al. 2022). This has special relevance to clinical fertility practice, because ovarian aging entails poor vascularization, oxidative stress by excessive free radicals, or advanced glycation end products in the follicular stromal neighborhood (Szafarowska and Jerzak 2013; Wood and Sills 2020; Mouanness et al. 2022). If autologous PRP can ameliorate these imbalances, the transformation for women’s health would be difficult to overstate.
In summary, it is generally agreed that PLT isolation technique, as well as activation and handling methods will determine both reagent quality (Bieback et al. 2019) and subsequent ovarian response (Sills 2022). Because there is considerable variation in PLT processing techniques and injection method, this lack of standardization has limited the clinical uptake of this investigational treatment (Rickers and Sills 2022). In the meantime, proposed PRP mechanisms of action have favored placing oocyte precursors or the follicle at center stage. However, the ovarian microclimate also does help direct egg development, so background modifications here by PRP could likewise influence follicle assembly and impact oocyte competency (Fiorentino et al. 2022).
Since cell groups beyond the follicle respond to intraovarian PRP, research on stromal PRP effects in non-reproductive tissue is relevant. Cytokines of PLT origin likely manifest congruent action in the adult human ovary; additional study can help delineate contributions autologous PRP may make which are synergistic with (yet distinct from) the oocyte or follicle.
Availability of data and materials
Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N (2006) Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290(6):C1532–C1542. https://doi.org/10.1152/ajpcell.00478.2005
Baca-Gonzalez L, Serrano Zamora R, Rancan L, González Fernández-Tresguerres F, Fernández-Tresguerres I, López-Pintor RM et al (2022) Plasma rich in growth factors (PRGF) and leukocyte-platelet rich fibrin (L-PRF): comparative release of growth factors and biological effect on osteoblasts. Int J Implant Dent 8(1):39. https://doi.org/10.1186/s40729-022-00440-4
Bhartiya D (2015) Ovarian stem cells are always accompanied by very small embryonic-like stem cells in adult mammalian ovary. J Ovarian Res 8:70. https://doi.org/10.1186/s13048-015-0200-0
Bhartiya D, Sharma D (2020) Ovary does harbor stem cells - size of the cells matters! J Ovarian Res 13(1):39. https://doi.org/10.1186/s13048-020-00647-2
Bieback K, Fernandez-Muñoz B, Pati S, Schäfer R (2019) Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: A joint publication from the AABB and the International Society for Cell & Gene Therapy. Transfusion 59(11):3448–3460. https://doi.org/10.1111/trf.15483
Cenni E, Ciapetti G, Granchi D, Fotia C, Perut F, Giunti A et al (2009) Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration. J Orthop Res 27(11):1493–1498. https://doi.org/10.1002/jor.20896
Fiorentino G, Cimadomo D, Innocenti F, Soscia D, Vaiarelli A, Ubaldi FM, Gennarelli G, Garagna S, Rienzi L, Zuccotti M (2022) Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility. Hum Reprod Update dmac031. https://doi.org/10.1093/humupd/dmac031
Hajipour H, Farzadi L, Latifi Z, Keyhanvar N, Navali N, Fattahi A et al (2021) An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: Clinical and molecular aspects. Syst Biol Reprod Med 67(3):177–188. https://doi.org/10.1080/19396368.2020.1862357
Hashem HR (2020) Regenerative and antioxidant properties of autologous platelet-rich plasma can reverse the aging process of the cornea in the rat model. Oxid Med Cell Longev 2020:4127959. https://doi.org/10.1155/2020/4127959
Heinzmann ACA, Coenen DM, Vajen T, Cosemans JMEM, Koenen RR (2021) Combined antiplatelet therapy reduces the proinflammatory properties of activated platelets. TH Open 5(4):e533–e542. https://doi.org/10.1055/a-1682-3415
Hynes RO, Naba A (2012) Overview of the matrisome—An inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol 4(1):a004903. https://doi.org/10.1101/cshperspect.a004903
Liu YH, To M, Okudera T, Wada-Takahashi S, Takahashi SS, Su CY et al (2022) Advanced platelet-rich fibrin (A-PRF) has an impact on the initial healing of gingival regeneration after tooth extraction. J Oral Biosci 64(1):141–147. https://doi.org/10.1016/j.job.2021.11.001
Luyckx V, Dolmans MM, Vanacker J, Legat C, Fortuño Moya C et al (2014) A new step toward the artificial ovary: Survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril 101(4):1149–1156. https://doi.org/10.1016/j.fertnstert.2013.12.025
Magistretti P, Bertossi D, Pirayesh A, Magistretti A, Chirumbolo S (2022) Exokine and the youth-boosting treatment based on one’s own serum: Wheat and chaff. Facial Plast Surg 38(2):177–181. https://doi.org/10.1055/s-0042-1747970
Miller CM, L Enninga EA, Rizzo SA, Phillipps J, Guerrero-Cazares H, Destephano CC et al (2022) Platelet-derived exosomes induce cell proliferation and wound healing in human endometrial cells. Regen Med. https://doi.org/10.2217/rme-2022-0095
Mouanness M, Nava H, Dagher C, Merhi Z (2022) Contribution of advanced glycation end products to PCOS key elements: A narrative review. Nutrients 14(17):3578. https://doi.org/10.3390/nu14173578
Moulavi F, Akram RT, Khorshid Sokhangouy S, Hosseini SM (2020) Platelet rich plasma efficiently substitutes the beneficial effects of serum during in vitro oocyte maturation and helps maintain mitochondrial activity of maturing oocytes. Growth Factors 38(3–4):152–166. https://doi.org/10.1080/08977194.2021.1900168
Nazari L, Salehpour S, Hoseini S, Zadehmodarres S, Ajori L (2016) Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod Biomed 14(10):625–628
Oktem O (2022) In response to: Why double ovarian stimulation in an in vitro fertilization cycle is potentially unsafe. Hum Reprod 37(8):1945–1947. https://doi.org/10.1093/humrep/deac127
Parte S, Bhartiya D, Manjramkar DD, Chauhan A, Joshi A (2013) Stimulation of ovarian stem cells by follicle stimulating hormone and basic fibroblast growth factor during cortical tissue culture. J Ovarian Res 6(1):20. https://doi.org/10.1186/1757-2215-6-20
Rao SS, Venkatesan J, Yuvarajan S, Rekha PD (2022) Self-assembled polyelectrolyte complexes of chitosan and fucoidan for sustained growth factor release from PRP enhance proliferation and collagen deposition in diabetic mice. Drug Deliv Transl Res 12(11):2838–2855. https://doi.org/10.1007/s13346-022-01144-3
Rastegar Adib F, Bagheri F, Sharifi AM (2022) Osteochondral regeneration in rabbit using xenograft decellularized ECM in combination with different biological products; platelet-rich fibrin, amniotic membrane extract, and mesenchymal stromal cells. J Biomed Mater Res B Appl Biomater 110(9):2089–2099. https://doi.org/10.1002/jbm.b.35063
Rickers NS, Sills ES (2022) Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal? Biomedicine (taipei) 12(4):1–8
Sak ME, Gul T, Evsen MS, Soydinc HE, Sak S, Ozler A et al (2013) Fibroblast growth factor-1 expression in the endometrium of patients with repeated implantation failure after in vitro fertilization. Eur Rev Med Pharmacol Sci 17(3):398–402
Scopelliti F, Cattani C, Dimartino V, Mirisola C, Cavani A (2022) Platelet derivatives and the immunomodulation of wound healing. Int J Mol Sci 23(15):8370. https://doi.org/10.3390/ijms23158370
Sills ES (2022) Why might ovarian rejuvenation fail? Decision analysis of variables impacting reproductive response after autologous platelet-rich plasma. Minerva Obstet Gynecol 74(4):377–385. https://doi.org/10.23736/S2724-606X.22.04996-X
Sills ES, Wood SH (2019) Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep 39(6):BSR20190805. https://doi.org/10.1042/BSR20190805
Sills ES, Wood SH (2022) Growth factors, gene activation, and cell recruitment: From intraovarian condensed platelet cytokines to de novo oocyte development. J Clin Transl Res 8(1):49–53
Sills ES, Rickers NS, Li X, Palermo GD (2018) First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol 34(9):756–760. https://doi.org/10.1080/09513590.2018.1445219
Sills ES, Rickers NS, Petersen JL, Li X, Wood SH (2020) Regenerative effect of intraovarian injection of autologous platelet rich plasma: Serum anti-Mullerian hormone levels measured among poor-prognosis in vitro fertilization patients. Int J Regen Med 3:1–5
Sills ES, Wood SH, Walsh APH (2022) Intraovarian condensed platelet cytokines for infertility and menopause—Mirage or miracle? Biochimie S0300–9084(22):00224–00233. https://doi.org/10.1016/j.biochi.2022.08.020
Szafarowska M, Jerzak M (2013) Ovarian aging and infertility. Ginekol Pol 84(4):298–304. https://doi.org/10.17772/gp/1580
Tocci A (2022) Reply: In response to: Why double ovarian stimulation in an in vitro fertilization cycle is potentially unsafe? Hum Reprod 37(8):1947–1949. https://doi.org/10.1093/humrep/deac128
Tuknayat A, Bhalla M, Thami GP (2021) Platelet-rich plasma is a promising therapy for melasma. J Cosmet Dermatol 20(8):2431–2436. https://doi.org/10.1111/jocd.14229
Virant-Klun I, Skutella T, Hren M, Gruden K, Cvjeticanin B, Vogler A et al (2013) Isolation of small SSEA-4-positive putative stem cells from the ovarian surface epithelium of adult human ovaries by two different methods. Biomed Res Int 2013:690415. https://doi.org/10.1155/2013/690415
Wagner M, Yoshihara M, Douagi I, Damdimopoulos A, Panula S, Petropoulos S et al (2020) Single-cell analysis of human ovarian cortex identifies distinct cell populations but no oogonial stem cells. Nat Commun 11(1):1147. https://doi.org/10.1038/s41467-020-14936-3
Wang J, Zhao Y, Zheng F, Ma N, Qin R, Qin W et al (2021) Activated human umbilical bord blood platelet-rich plasma enhances the beneficial effects of human umbilical cord mesenchymal stem cells in chemotherapy-induced POF rats. Stem Cells Int 2021:8293699. https://doi.org/10.1155/2021/8293699
White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL (2012) Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 18(3):413–421. https://doi.org/10.1038/nm.2669
Wood SH, Sills ES (2020) Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes. Clin Exp Reprod Med 47(2):94–100. https://doi.org/10.5653/cerm.2019.03405
Wu MJM, Sermer C, Kandel RA, Theodoropoulos JS (2022) Characterization of migratory cells from bioengineered bovine cartilage in a 3D co-culture model. Am J Sports Med 50(11):3090–3101. https://doi.org/10.1177/03635465221113325
Yunus M, Massi MN, Anwar AI, Djawad K, Wahab S (2022) The use of autologous serum in dermatology. Skinmed 20(2):97–104
Zhao M, Wang J, Zhang J, Huang J, Luo L, Yang Y et al (2022) Functionalizing multi-component bioink with platelet-rich plasma for customized in-situ bilayer bioprinting for wound healing. Mater Today Bio 16:100334. https://doi.org/10.1016/j.mtbio.2022.100334
Ethics approval and consent to participate
Consent for publication
U.S. Trademark #88505430 has been awarded to ESS for specified process and method using autologous platelet cytokines for ovarian therapy.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sills, E.S., Wood, S.H. Discussion of field effects after intraovarian injection of autologous platelet-rich plasma. Bull Natl Res Cent 47, 52 (2023). https://doi.org/10.1186/s42269-023-01028-7